Therapeutic potential of RAS prenylation pharmacological inhibitors in the treatment of breast cancer, recent progress, and prospective-Reference-Cited by-同舟云学术

Therapeutic potential of RAS prenylation pharmacological inhibitors in the treatment of breast cancer, recent progress, and prospective

Published:2018-10-30 Issue:5 Volume:120 Page:6860-6867
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Soleimani Atena¹²,Amirinejad Mostafa³⁴,Rahsepar Sara³,Vazirian Fatemeh³,Bahrami Afsane⁵,Ferns Gordon A.⁶,Khazaei Majid⁷⁸,Avan Amir⁸⁹^ORCID,Hassanian Seyed Mahdi¹⁸^ORCID

Affiliation:

1. Department of Clinical Biochemistry Faculty of Medicine, Mashhad University of Medical Sciences Mashhad Iran

2. Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences Mashhad Iran

3. School of Pharmacy, Mashhad University of Medical Sciences Mashhad Iran

4. Student Research Committee, School of Pharmacy, Mashhad University of Medical Sciences Mashhad Iran

5. Cellular and Molecular Research Center, Birjand University of Medical Sciences Birjand Iran

6. Division of Medical Education Brighton & Sussex Medical School Brighton UK

7. Department of Medical Physiology Faculty of Medicine, Mashhad University of Medical Sciences Mashhad Iran

8. Metabolic Syndrome Research Center, Mashhad University of Medical Sciences Mashhad Iran

9. Department of Modern Sciences and Technologies Faculty of Medicine, Mashhad University of Medical Sciences Mashhad Iran

Funder

Mashhad University of Medical Sciences

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27992

Reference50 articles.

1. Emerging ways to treat breast cancer: will promises be met?

2. Breast cancer: early diagnosis and effective treatment by drug delivery tracing

3. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs

4. Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer

5. Ras in Cancer and Developmental Diseases

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CaaX-motif-adjacent residues influence G protein gamma (Gγ) prenylation under suboptimal conditions;Journal of Biological Chemistry;2023-11

2. HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy;Cell Death & Disease;2022-11-18

3. Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer;Breast Disease;2021-06-18

4. Therapeutic potential of renin angiotensin system inhibitors in cancer cells metastasis;Pathology - Research and Practice;2020-07

5. MicroRNAs as novel targets of sulforaphane in cancer therapy: The beginning of a new tale?;Phytotherapy Research;2020-01-23